Clinical Biochemistry Department, College of Medicine, Jagiellonian University, Wielicka Street 265, 30-663 Kracow, Poland.
Int J Endocrinol. 2012;2012:712425. doi: 10.1155/2012/712425. Epub 2012 May 14.
Blood hormone and tumor marker concentrations are usually determined by immunochemical methods which are based on an unique reaction between antigen and assay capture antibody. Despite the speed and simplicity of assays performance on automatic immunochemistry platforms, the interpretation of final results requires a deep knowledge of method fallibility. General lack of immunoassays standardization, presence of cross-reacting substances in patient's sample, limitation of free hormones measurement due to abnormal analyte binding protein concentrations, assay interferences due to patient's autoantibodies, and heterophilic antibodies, as well as proper interpretation of very low- and very high-sample analyte levels, are the main points discussed in respect to hormones and tumor markers measurement in geriatric population.
血液激素和肿瘤标志物的浓度通常通过免疫化学方法来确定,该方法基于抗原和检测捕获抗体之间的独特反应。尽管在自动免疫化学平台上进行检测具有速度快、操作简单的特点,但对最终结果的解释需要深入了解方法的易错性。一般来说,免疫检测缺乏标准化,患者样本中存在交叉反应物质,由于分析物结合蛋白浓度异常导致游离激素的测量受限,由于患者自身抗体和异嗜性抗体导致检测干扰,以及对极低和极高样本分析物水平的正确解释,这些都是在老年人群中测量激素和肿瘤标志物时需要讨论的要点。